US News & World Report: Immunotherapy and cancer, COVID-19
UC research presented at virtual American Association for Cancer Research meeting
Immunotherapy for cancer patients with COVID-19 appears safe, a preliminary study suggests.
This form of treatment activates a person's immune system to fight against cancer.
Researchers have been wary because many COVID-19 complications result from an overactive immune response that leads to increased production of proteins called cytokines, which can cause issues such as respiratory failure.
"In patients with both COVID-19 and cancer, our team thought that immunotherapy might increase the immune system response, which could already be overactive because of the COVID-19 infection," researcher and UC postdoctoral fellow Layne Weatherford said.
Weatherford works in the lab of Trisha Wise-Draper, PhD, an associate professor of medicine, Division of Hematology Oncology, at the UC College of Medicine, UC Health oncologist and medical director of the UC Cancer Center Clinical Trials Office.
Read the full story, which was originially reported by HealthDay News and also featured on the WebMD website, Everyday Health and at Drugs.com.
Read the UC news release on this research.
Featured photo of test tubes by Colleen Kelley/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
A picture-perfect finish for innovation at CEAS EXPO 2026
April 9, 2026
The CEAS EXPO 2026 brought together UC’s brightest engineers to display their forward-thinking projects, with multispectral camera Kromico earning the 1819 Innovation Award.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.